Filtros de búsqueda

Lista de obras de Cristina Papayannidis

A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.

artículo científico publicado en 2015

A case report of acute myeloid leukemia and neurofibromatosis 1.

artículo científico publicado en 2013

A phase 2 study of MK-0457 in patients with BCR-ABL T315I mutant chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.

artículo científico publicado en 2014

A polymorphism in the chromosome 9p21 ANRIL locus is associated to Philadelphia positive acute lymphoblastic leukemia

artículo científico publicado en 2011

AICDA expression in BCR/ABL1-positive acute lymphoblastic leukaemia is associated with a peculiar gene expression profile

artículo científico publicado en 2011

Acute Myeloid Leukemia Mutations: Therapeutic Implications

scientific article published on 03 June 2019

Allogeneic stem cell transplantation for advanced acute promyelocytic leukemia in the ATRA and ATO era

artículo científico publicado en 2012

Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery

artículo científico publicado en 2018

Application of the whole-transcriptome shotgun sequencing approach to the study of Philadelphia-positive acute lymphoblastic leukemia.

artículo científico publicado en 2012

B-cell acute lymphoblastic leukemia as evolution of a 8p11 myeloproliferative syndrome with t(8;22)(p11;q11) and BCR-FGFR1 fusion gene.

artículo científico publicado en 2010

Blinatumomab in Ph+ B-ALL: present and perspectives

artículo científico publicado en 2017

CDKN2A/B alterations impair prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia patients.

artículo científico publicado en 2011

Chromothripsis in acute myeloid leukemia: biological features and impact on survival

artículo científico publicado en 2018

Clinical and experimental efficacy of gemtuzumab ozogamicin in core binding factor acute myeloid leukemia.

artículo científico publicado en 2017

Clinical impact of low-burden BCR-ABL1 mutations detectable by amplicon deep sequencing in Philadelphia-positive acute lymphoblastic leukemia patients.

artículo científico publicado en 2016

Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients

artículo científico publicado en 2016

Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia

artículo científico publicado en 2018

Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter S

article

Complete paraplegia after nelarabine treatment in a T-cell acute lymphoblastic leukemia adult patient

artículo científico publicado en 2010

Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities

Complex karyotype, older age, and reduced first-line dose intensity determine poor survival in core binding factor acute myeloid leukemia patients with long-term follow-up.

artículo científico publicado en 2015

Cytogenetic and molecular predictors of outcome in acute lymphocytic leukemia: recent developments

artículo científico publicado en 2012

Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR-ABL1-positive acute lymphoblastic leukemia patients.

artículo científico publicado en 2009

Drug resistance and BCR-ABL kinase domain mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia from the imatinib to the second-generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in t

scientific article published on 30 December 2013

Efficacy of Azacitidine in the treatment of adult patients aged 65 years or older with AML.

artículo científico publicado en 2016

Epigenetically induced ectopic expression of UNCX impairs the proliferation and differentiation of myeloid cells

artículo científico publicado en 2017

Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance

artículo científico publicado en 2008

FGFR1 and KAT6A rearrangements in patients with hematological malignancies and chromosome 8p11 abnormalities: biological and clinical features.

artículo científico publicado en 2016

Flai (fludarabine, cytarabine, idarubicin) plus low-dose gemtuzumab ozogamicin as induction therapy in cd33-positive aml: Final results and long term outcome of a phase ii multicenter clinical trial

artículo científico publicado en 2018

IKAROS deletions dictate a unique gene expression signature in patients with adult B-cell acute lymphoblastic leukemia

artículo científico publicado en 2012

IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report

artículo científico publicado en 2009

IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia

artículo científico publicado en 2015

Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute

artículo científico publicado en 2009

Identification of different Ikaros cDNA transcripts in Philadelphia-positive adult acute lymphoblastic leukemia by a high-throughput capillary electrophoresis sizing method

article published in 2008

In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia

artículo científico publicado en 2015

Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia

artículo científico publicado en 2018

Larger Size of Donor Alloreactive NK Cell Repertoire Correlates with Better Response to NK Cell Immunotherapy in Elderly Acute Myeloid Leukemia Patients

artículo científico publicado en 2016

Leukemia cutis in a Ph+ ALL patient treated with ponatinib

artículo científico publicado en 2018

Low-Dose Anti-T Lymphoglobulin as Prophylaxis for Graft-versus-Host Disease in Unrelated Donor Transplantations for Acute Leukemias and Myelodysplastic Syndromes

artículo científico publicado en 2018

Molecular and chromosomal alterations: new therapies for relapsed acute myeloid leukemia

artículo científico publicado en 2008

Myeloid sarcoma of liver: an unusual cause of jaundice. Report of three cases and review of literature

artículo científico publicado en 2007

New targets for Ph+ leukaemia therapy

scientific article published on September 2009

Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patients

artículo científico publicado en 2016

Optimized pipeline of MuTect and GATK tools to improve the detection of somatic single nucleotide polymorphisms in whole-exome sequencing data

artículo científico publicado en 2016

Paraplegia due to a paravertebral extramedullary haemopoiesis in a patient with polycythaemia vera

artículo científico publicado en 2007

Patient with ataxia telangiectasia who developed acute myeloid leukemia

artículo científico publicado en 2011

Phase I clinical study of RG7356, an anti-CD44 humanized antibody, in patients with acute myeloid leukemia

artículo científico publicado en 2016

Philadelphia positive (Ph+) acute lymphoblastic leukemia (ALL) patient with breast infiltration

artículo científico publicado en 2010

Philadelphia-positive acute lymphoblastic leukemia patients already harbor BCR-ABL kinase domain mutations at low levels at the time of diagnosis

artículo científico publicado en 2010

Philadelphia-positive patients who already harbor imatinib-resistant Bcr-Abl kinase domain mutations have a higher likelihood of developing additional mutations associated with resistance to second- or third-line tyrosine kinase inhibitors.

artículo científico publicado en 2009

Posterior reversible encephalopathy syndrome in a B-cell acute lymphoblastic leukemia young adult patient treated with a pediatric-like chemotherapeutic schedule

artículo científico publicado en 2014

Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia

artículo científico publicado en 2016

Primary cardiac non-Hodgkin lymphoma presenting with atrial flutter and pericardial effusion

artículo científico publicado en 2006

Rationale for a pediatric-inspired approach in the adolescent and young adult population with acute lymphoblastic leukemia, with a focus on asparaginase treatment

artículo científico publicado en 2014

Recurrent Gastrointestinal Hemorrhage in Treatment with Dasatinib in a Patient Showing SMAD4 Mutation with Acute Lymphoblastic Leukemia Philadelphia Positive and Juvenile Polyposis Hereditary Hemorrhagic Telangiectasia Syndrome

artículo científico publicado en 2013

Revealing very small FLT3 ITD mutated clones by ultra-deep sequencing analysis has important clinical implications in AML patients

artículo científico publicado en 2015

SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis

artículo científico publicado en 2017

Successful combination treatment of clofarabine, cytarabine, and gemtuzumab-ozogamicin in adult refractory B-acute lymphoblastic leukemia

artículo científico publicado en 2009

Targeting the p53-MDM2 interaction by the small-molecule MDM2 antagonist Nutlin-3a: a new challenged target therapy in adult Philadelphia positive acute lymphoblastic leukemia patients

artículo científico publicado en 2016

The Italian Mastocytosis Registry: 6-year experience from a hospital-based registry

artículo científico publicado en 2018

The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party

artículo científico publicado en 2010

The clonal evolution of two distinct T315I-positive BCR-ABL1 subclones in a Philadelphia-positive acute lymphoblastic leukemia failing multiple lines of therapy: a case report

artículo científico publicado en 2017

Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: a phase 1 safety and pharmacokinetics study.

artículo científico publicado en 2015

Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis

artículo científico publicado en 2017

Tyrosine kinase inhibitors in Ph+ acute lymphoblastic leukaemia: facts and perspectives

artículo científico publicado en 2016

Unraveling the complexity of tyrosine kinase inhibitor-resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain

artículo científico publicado en 2013

Use of a high sensitive nanofluidic array for the detection of rare copies of BCR-ABL1 transcript in patients with Philadelphia-positive acute lymphoblastic leukemia in complete response

artículo científico publicado en 2014

Use of single nucleotide polymorphism array technology to improve the identification of chromosomal lesions in leukemia

artículo científico publicado en 2013

[Molecular biology in myelodysplastic syndromes and acute myeloid leukemias "smoldering"]

artículo científico publicado en 2014